Absci Corporation (ABSI)
NASDAQ: ABSI · Real-Time Price · USD
3.900
-0.050 (-1.27%)
Apr 21, 2026, 11:27 AM EDT - Market open
Absci Market Cap
Absci has a market cap or net worth of $596.78 million as of April 21, 2026. Its market cap has increased by 109.67% in one year.
Market Cap
596.78M
Enterprise Value
465.44M
1-Year Change
109.67%
Ranking
Category
Stock Price
$3.90
Market Cap Chart
Since the IPO on July 22, 2021, Absci's market cap has increased from $423.19M to $596.78M, an increase of 41.02%. That is a compound annual growth rate of 7.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 604.43M | 15.17% |
| Dec 31, 2025 | 524.80M | 74.40% |
| Dec 31, 2024 | 300.92M | -22.91% |
| Dec 29, 2023 | 390.34M | 101.18% |
| Dec 30, 2022 | 194.03M | -74.44% |
| Dec 31, 2021 | 759.25M | 79.41% |
| Jul 22, 2021 | 423.19M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lyell Immunopharma | 560.11M |
| Tectonic Therapeutic | 554.10M |
| AgomAb Therapeutics NV | 552.19M |
| Fulcrum Therapeutics | 552.12M |
| Zura Bio | 551.26M |
| Immix Biopharma | 548.68M |
| ADC Therapeutics | 543.75M |
| Upstream Bio | 543.66M |